Real-time fluorescence imager improves breast cancer outcomes
The device allows surgeons to scan tissue within the surgical cavity to observe residual cancer cells. Image: National Institutes of Health
Developed by MIT spinout Lumicell, the handheld device uses cameras and light-sensitive imaging agents to reveal residual cancer cells
Register for FREE to keep reading
Join 15,000+ photonics professionals staying ahead with:
- Exclusive insights, funding alerts & market trends
- Curated newsletters and digital editions
- Access to The Photonics100 list of R&D champions
- Exclusive panels & roundtables for professional development
- Technical White Papers & product updates to guide smarter decisions
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
